• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513730
Device Problems Break (1069); Unraveled Material (1664); Activation, Positioning or Separation Problem (2906); Material Deformation (2976); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/27/2022
Event Type  malfunction  
Manufacturer Narrative
Initial reporter facility name: (b)(6).Imdrf device code a040508 captures the reportable product investigation result of stent unraveled.Imdrf device code a0401 captures the reportable product investigation result of stent detached/separated.An ultraflex esophageal stent and delivery system were returned for analysis.Media inspection was performed based on the photo provided by the complainant and showed the shaft was bent in two sections and the stent was fully deployed.Visual examination of the returned device found the stent was fully deployed and expanded.The stent wires were unraveled and broken, and the shaft was bent.No other issues were noted to the stent and delivery system.Product analysis did not confirm the reported event of stent partially deployed; the stent was returned fully deployed and expanded.However, the reported device malfunction of shaft bent was confirmed.The damages noted were most likely due to procedural factors encountered during the procedure, such as lesion characteristics, handling of the device, the techniques used by the user, limited the performance of the device and could have caused kinking of the delivery shaft.Additionally, handling and manipulation of the stent during removal could have resulted to stent wire broke and unraveled.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to procedure.A product labeling review identified that the device was used per the directions for use (dfu) / product label.
 
Event Description
It was reported to boston scientific corporation that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a 6cm malignant esophageal stricture during an esophageal stent placement procedure performed on (b)(6) 2022.The patient anatomy was not tortuous and was dilated prior to stent placement.During the procedure, after opening the package, the black stent deployment suture unraveled, and the stent was deployed partially.The procedure was completed with a wallflex esophageal stent.There were no patient complications reported.A photo of the complaint device was provided by the complainant and showed the shaft was bent and the stent was fully deployed and expanded.It is possible that the physician fully deployed the stent outside the patient.Note: this complaint has been deemed an mdr reportable event based on the product investigation which revealed that the stent wire break and unravel.
 
Manufacturer Narrative
Blocks b5 and h6 have been updated with the additional information received on january 30, 2024.Block e1: initial reporter facility name: (b)(6).Block h6: imdrf device code a040508 captures the reportable product investigation result of stent unraveled.Imdrf device code a0401 captures the reportable product investigation result of stent detached/separated.Block h10: an ultraflex esophageal stent and delivery system were returned for analysis.Media inspection was performed based on the photo provided by the complainant and showed the shaft was bent in two sections and the stent was fully deployed.Visual examination of the returned device found the stent was fully deployed and expanded.The stent wires were unraveled and broken, and the shaft was bent.No other damages were noted to the stent and delivery system.Product analysis did not confirm the reported event of stent partially deployed; the stent was returned fully deployed and expanded.However, the reported device malfunction of shaft bent was confirmed.The damages noted were most likely due to procedural factors encountered during the procedure, such as lesion characteristics, handling of the device, the techniques used by the user, limited the performance of the device and could have caused kinking of the delivery shaft.Additionally, handling and manipulation of the stent during removal could have resulted to stent wire broke and unraveled.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to procedure.A product labeling review identified that the device was used per the directions for use (dfu) / product label.
 
Event Description
It was reported to boston scientific corporation that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a 6cm malignant esophageal stricture during an esophageal stent placement procedure performed on (b)(6) 2022.The patient anatomy was not tortuous and was dilated prior to stent placement.During the procedure, after opening the package, the black stent deployment suture unraveled, and the stent was deployed partially.The procedure was completed with a wallflex esophageal stent.There were no patient complications reported.A photo of the complaint device was provided by the complainant and showed the shaft was bent and the stent was fully deployed and expanded.It is possible that the physician fully deployed the stent outside the patient.Note: this complaint has been deemed an mdr reportable event based on the product investigation which revealed that the stent wire break and unravel.Additional information received on january 30, 2024.It was reported that the procedure on (b)(6) 2022, was not completed, and the wallflex esophageal stent was implanted during a second procedure performed on (b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16709044
MDR Text Key312976277
Report Number3005099803-2023-01814
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716150
UDI-Public08714729716150
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/20/2023
Device Model NumberM00513730
Device Catalogue Number1373
Device Lot Number0028049366
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/16/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/25/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
Patient SexMale
Patient Weight60 KG
-
-